Verastem | VSTM - Net Income

Verastem reported $-16808000 in Net Income for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Net Income Change
Abbvie ABBV:US USD 2.47B 1.48B
AstraZeneca AZN:LN USD 901M 739M
Cytokinetics CYTK:US USD -137380000 4.93M
Gilead Sciences GILD:US USD 1.64B 149M
Immunogen IMGN:US USD -59008000 18.75M
Laboratory Of America LH:US USD 76.1M 276.7M
Novartis NOVN:VX USD 1.47B 107M
Pfizer PFE:US USD 5B 3.61B
Roche Holding ROG:VX 3.89B 4.64B
Tg Therapeutics TGTX:US USD -52994000 17.18M
Verastem VSTM:US USD -16808000 1.28M
YTE INCY:US USD 28.46M 84.31M
Ziopharm Oncology ZIOP:US USD -9159000 308K